Myriad Genetics (NASDAQ:MYGN) is gearing up to announce its quarterly earnings on Tuesday, 2025-08-05. Here’s a quick overview of what investors should know before the release.

Analysts are estimating that Myriad Genetics will report an earnings per share (EPS) of $-0.05.

Investors in Myriad Genetics are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It’s …

Full story available on Benzinga.com